Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetrandrine Injection with Thoracic Radiotherapy for Thoracic Tumors
ChiCTR2500111007Phase 2Recruiting
- Sponsor
- People's Hospital of Chongqing Hechuan
- Start
- Oct 2025
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Intrathoracic Neoplasm, esophageal cancer and bronchial carcinoma comparing Tetrandrine + thoracic radiotherapy with Control: Placebo + thoracic radiotherapy (2 arms). Primary endpoints: Incidence of radiation pneumonitis and Incidence of radiation-induced pulmonary fibrosis. Started Oct 2025; status: recruiting.
02
Drugs
tetrandrine
03
Conditions
Intrathoracic Neoplasmesophageal cancerbronchial carcinoma
Beyond the preview
Go deeper on ChiCTR2500111007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500111007.